Product Information
PAROXETINE HCL 10 MG/5 ML SUSP is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $1.4001 per ML under NDC 70954031910. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Sep 3, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/5mL
Manufacturer
ANI Pharmaceuticals, Inc.NDC
70954031910
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PAROXETINE HYDROCHLORIDE HEMIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA215003FDA Approved
9/3/2021
TE Code
AB
On Market Since
9/3/2021
Pharmacological Classes
Price Statistics
The NADAC for PAROXETINE HCL 10 MG/5 ML SUSP has been published 129 times since Apr 17, 2024, and over the history we have for it it has risen 5.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4001 per ML |
|---|---|
| All-time high | $1.4041 (Sep 16, 2026) |
| All-time low | $1.2247 (Sep 18, 2024) |
| 52-week high | $1.4041 |
| 52-week low | $1.3280 |
| Median price | $1.3429 |
| Average price | $1.3345 |
| Largest weekly change | -4.9% (Jul 17, 2024) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Paroxetine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ANI Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Paroxetine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PAROXETINE HCL 10 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for PAROXETINE HCL 10 MG/5 ML SUSP, manufactured by ANI Pharmaceuticals, Inc., is $1.4001 per ML (NDC 70954031910), effective Sep 30, 2026.
How has the price of PAROXETINE HCL 10 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for PAROXETINE HCL 10 MG/5 ML SUSP has risen 5.7%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for PAROXETINE HCL 10 MG/5 ML SUSP?
Since Apr 17, 2024, the NADAC for PAROXETINE HCL 10 MG/5 ML SUSP has ranged from a low of $1.2247 (Sep 18, 2024) to a high of $1.4041 (Sep 16, 2026), with a median of $1.3429 per ML.
Are there cheaper alternatives to PAROXETINE HCL 10 MG/5 ML SUSP?
No other NADAC-published product currently shares the active ingredient and strength of PAROXETINE HCL 10 MG/5 ML SUSP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PAROXETINE HCL 10 MG/5 ML SUSP?
PAROXETINE HCL 10 MG/5 ML SUSP (NDC 70954031910) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.